(Q44039658)

English

Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase.

scientific article published in July 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Thymosin-alpha1 and famciclovir combination therapy activates T-cell response in patients with chronic hepatitis B virus infection in immune-tolerant phase (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Hepatitis B virus

1 reference

based on heuristic

inferred from title

chronic hepatitis B

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

G K K Lau

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Nanji

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

J Hou

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

W-S Au

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S-T Yuen

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Lin

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H-F Kung

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

S-K Lam

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Journal of Viral Hepatitis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

280-287

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12081605%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Chronic hepatitis B virus infection: treatment strategies for the next millennium

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Natural history and control of perinatally acquired hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Hepatitis B virus immunopathology

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

The serology of chronic hepatitis B infection revisited

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Combination chemotherapy for hepatitis B virus: the final solution?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Lamivudine and alpha interferon combination treatment of patients with chronic hepatitis B infection: a randomised trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Combination therapy with lamivudine and famciclovir for chronic hepatitis B-infected Chinese patients: a viral dynamics study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

A cell culture assay for compounds which inhibit hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Famciclovir in chronic hepatitis B: results of a dose-finding study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Thymosin alpha1 treatment of chronic hepatitis B: results of a phase III multicentre, randomized, double-blind and placebo-controlled study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Genotypes, nt 1858 variants, and geographic origin of hepatitis B virus--large-scale analysis using a new genotyping method

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Hepatic expression of hepatitis B virus genome in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Interleukin-12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Which patients with chronic hepatitis B virus infection will respond to alpha-interferon therapy? A statistical analysis of predictive factors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

A case for cytokines as effector molecules in the resolution of virus infection

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Defining protective responses to pathogens: cytokine profiles in leprosy lesions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Thymosin treatment of chronic hepatitis B: a placebo-controlled pilot trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Clearance of hepatitis B surface antigen after bone marrow transplantation: Role of adoptive immunity transfer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

A controlled trial of interferon with or without prednisone priming for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.2002.00361.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44039658&oldid=2105862091"